Form 4 for EW Edwards Lifesciences
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-18 · accession 0001225208-21-013981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-19 | 2021-11-18 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| DM | 2021-11-19 | 2021-11-18 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $117.79 | -10.0K | 27.4K | -27% | -$1.18M |
| D | 2021-11-19 | 2021-11-18 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | -10.0K | 103.4K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | M | A | 10,000 | $21.76 | 37,414.52 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-18 | S | D | 1,253 | $118.87 | 36,161.52 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $118.5900 to $118.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-18 | S | D | 2,390 | $116.98 | 33,771.52 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $116.4900 to $117.3600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2021-11-18 | S | D | 6,357 | $117.88 | 27,414.52 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $117.5790 to $118.4800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Derivative | Employee Stock Option (Right to Acquire) | 2021-11-18 | M | D | 10,000 | $0.00 | 103,400 | D | $21.76 · 2016-05-14 to 2022-05-13 | 10,000 Common Stock |